Your browser doesn't support javascript.
loading
Patterns, predictors and prognostic relevance of high-grade hematotoxicity after temozolomide or temozolomide-lomustine in the CeTeG/NOA-09 trial.
Weller, J; Schäfer, N; Schaub, C; Tzaridis, T; Zeyen, T; Schneider, M; Potthoff, A L; Giordano, F A; Steinbach, J P; Zeiner, P S; Kowalski, T; Sabel, M; Hau, P; Krex, D; Grauer, O; Goldbrunner, R; Schnell, O; Tabatabai, G; Ringel, F; Schmidt-Graf, F; Brehmer, S; Tonn, J C; Bullinger, L; Vajkoczy, P; Glas, M; Vatter, H; Herrlinger, U; Seidel, C.
Afiliación
  • Weller J; Division of Clinical Neurooncology, Department of Neurology and Center of Integrated Oncology (CIO), University Hospital Bonn, Venusberg-Campus 1, 53105, Bonn, Germany. johannes.weller@ukbonn.de.
  • Schäfer N; Division of Clinical Neurooncology, Department of Neurology and Center of Integrated Oncology (CIO), University Hospital Bonn, Venusberg-Campus 1, 53105, Bonn, Germany.
  • Schaub C; Division of Clinical Neurooncology, Department of Neurology and Center of Integrated Oncology (CIO), University Hospital Bonn, Venusberg-Campus 1, 53105, Bonn, Germany.
  • Tzaridis T; Division of Clinical Neurooncology, Department of Neurology and Center of Integrated Oncology (CIO), University Hospital Bonn, Venusberg-Campus 1, 53105, Bonn, Germany.
  • Zeyen T; Division of Clinical Neurooncology, Department of Neurology and Center of Integrated Oncology (CIO), University Hospital Bonn, Venusberg-Campus 1, 53105, Bonn, Germany.
  • Schneider M; Department of Neurosurgery, University Hospital Bonn, Venusberg-Campus 1, Bonn, Germany.
  • Potthoff AL; Department of Neurosurgery, University Hospital Bonn, Venusberg-Campus 1, Bonn, Germany.
  • Giordano FA; Department of Radiation Oncology, University Medical Center Mannheim, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany.
  • Steinbach JP; Dr. Senckenberg Institute of Neurooncology, University of Frankfurt, Frankfurt, Germany.
  • Zeiner PS; Dr. Senckenberg Institute of Neurooncology, University of Frankfurt, Frankfurt, Germany.
  • Kowalski T; Department of Neurology, University Hospital Knappschaftskrankenhaus, Ruhr-Universität Bochum, Bochum, Germany.
  • Sabel M; Department of Neurosurgery, University of Düsseldorf, Düsseldorf, Germany.
  • Hau P; Department of Neurology and Wilhelm Sander NeuroOncology Unit, University Hospital Regensburg, Regensburg, Germany.
  • Krex D; Department of Neurosurgery, University of Dresden, Dresden, Germany.
  • Grauer O; Department of Neurology, University of Münster, Münster, Germany.
  • Goldbrunner R; Department of General Neurosurgery, Center of Neurosurgery, University of Cologne, Cologne, Germany.
  • Schnell O; Department of Neurosurgery, University of Freiburg, Freiburg, Germany.
  • Tabatabai G; Department of Neurology and Interdisciplinary Neurooncology, University Hospital Tübingen, Hertie Institute for Clinical Brain Research, Center for Neuro-Oncology, Comprehensive Cancer Center Tübingen-Stuttgart, German Cancer Consortium (DKTK), Partner site Tübingen, Eberhard Karls University, Tübin
  • Ringel F; Department of Neurosurgery, University of Mainz, Mainz, Germany.
  • Schmidt-Graf F; Department of Neurology, Technical University of Munich, Munich, Germany.
  • Brehmer S; Department of Neurosurgery, University of Mannheim, Mannheim, Germany.
  • Tonn JC; Department of Neurosurgery, Ludwig Maximillian University of Munich and German Cancer Consortium (DKTK), Partner Site Munich, Munich, Germany.
  • Bullinger L; Department of Hematology, Oncology and Tumorimmunology, Charité University of Berlin, Berlin, Germany.
  • Vajkoczy P; Department of Neurosurgery, Charité University of Berlin, Berlin, Germany.
  • Glas M; Division of Clinical Neurooncology, Department of Neurology and West German Cancer Center (WTZ), German Cancer Consortium, Partner Site Essen, University Hospital Essen, Essen, Germany.
  • Vatter H; Department of Neurosurgery, University Hospital Bonn, Venusberg-Campus 1, Bonn, Germany.
  • Herrlinger U; Division of Clinical Neurooncology, Department of Neurology and Center of Integrated Oncology (CIO), University Hospital Bonn, Venusberg-Campus 1, 53105, Bonn, Germany.
  • Seidel C; Department of Radiation Oncology, University of Leipzig, Leipzig, Germany.
J Neurooncol ; 161(1): 147-153, 2023 Jan.
Article en En | MEDLINE | ID: mdl-36609807
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasias Encefálicas / Glioblastoma Tipo de estudio: Clinical_trials / Prognostic_studies / Risk_factors_studies Límite: Female / Humans Idioma: En Revista: J Neurooncol Año: 2023 Tipo del documento: Article País de afiliación: Alemania
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasias Encefálicas / Glioblastoma Tipo de estudio: Clinical_trials / Prognostic_studies / Risk_factors_studies Límite: Female / Humans Idioma: En Revista: J Neurooncol Año: 2023 Tipo del documento: Article País de afiliación: Alemania